Now funded by the Eli Lilly and Company Foundation, the Lilly MDR-TB Partnership brings together government leaders, global health organizations, country-level healthcare providers, community and advocacy organizations and other stakeholders to increase the availability of quality-assured medicine used to treat MDR-TB, enhance education for healthcare professionals where the need is greatest, and